# Implantation or Injectable Dosage Form New Animal Drugs; Xylazine Injection
> **US Department of Health and Human Services** · Final rule. · Published 1995-07-06 · Effective 1995-07-06 · 60 FR 35123
## Document
- **Document number:** 95-16626
- **Category:** other
- **Sub-agency:** US Department of Health and Human Services
- **Federal Register citation:** 60 FR 35123
- **CFR reference:** 21 CFR 522
- **Publication date:** 1995-07-06
- **Effective date:** 1995-07-06
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Lloyd, Inc. The supplemental NADA provides for intramuscular use in Cervidae spp. of xylazine injection to produce sedation accompanied by a shorter period of analgesia.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1995/07/06/95-16626/implantation-or-injectable-dosage-form-new-animal-drugs-xylazine-injection)
---
*AI Analytics · CC0 1.0*